483
Capstone Clinical Trials, Inc.Capstone Clinical Trials, Inc. – FDA 483, Feb 17, 2009
Record Details
Capstone Clinical Trials, Inc. in Birmingham, AL, received a Form FDA 483 with five observations related to clinical trial conduct. The inspection revealed issues including inadequate documentation for subject unblinding, lack of IRB approval for off-site study activities and subject reimbursement, and discrepancies in study closure reporting. Additionally, the firm failed to accurately document delegation of duties and did not adhere to the protocol for subject randomization.
View Company Profile
ID · 6f7d0f2f-7df5-4c11-be8c-43732561366b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.